Mode
Text Size
Log in / Sign up

U.S. tuberculosis incidence data reported for 2021 in observational analysis

U.S. tuberculosis incidence data reported for 2021 in observational analysis
Photo by Cht Gsml / Unsplash
Key Takeaway
Note: 2021 U.S. TB incidence data is observational; detailed rates and methods are not reported.

An observational report provided data on tuberculosis incidence within the United States population for the year 2021. The analysis did not specify a sample size, a particular intervention or exposure, or a comparator group. The primary outcome was the incidence of tuberculosis, but the exact rate, effect size, absolute numbers, and statistical measures were not reported in the provided data.

No information on safety, adverse events, or tolerability was available from this report. The funding sources and potential conflicts of interest were also not reported.

Key limitations include the lack of detailed methodological reporting, such as sample size and specific incidence figures. The absence of a comparator or intervention analysis restricts causal inference. For clinical practice, this report serves as a basic surveillance update; clinicians should refer to official public health sources like the CDC for complete annual tuberculosis statistics and trends.

Study Details

EvidenceLevel 5
PublishedMar 2022
View Original Abstract ↓
This report describes tuberculosis incidence in the U.S. during 2021.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.